Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-04-24

FDA Approved: PIVYA — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves PIVYA (pivmecillinam) from Alembic Pharmaceuticals Inc. under an original NDA for urinary tract infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIVYA (PIVMECILLINAM)

Snippet

ORIG AP for PIVYA (PIVMECILLINAM)